Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Isopto carpine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,360Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDC’s Generics Pilocarpine Hydrochloride Receives Approval in US
    FDC’s Generics Pilocarpine Hydrochloride Receives Approval in US

    02 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217052

    FDA
    02 Oct 2025
    Share Share
    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea
    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-licensing-agreement-with-optus-pharmaceuticals-for-commercialization-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-in-korea-302277027.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    TB, Asthma, Glaucoma, Bipolar Meds To Rise By 50% Cost by NPPA
    TB, Asthma, Glaucoma, Bipolar Meds To Rise By 50% Cost by NPPA

    15 Oct 2024

    // FINANCIALXPRESS

    https://www.financialexpress.com/business/healthcare-tuberculosis-asthma-glaucoma-and-bipolar-disorder-medicines-to-get-costlier-by-50-percent-as-nppa-announces-price-hike-3641256/

    FINANCIALXPRESS
    15 Oct 2024
    Share Share
    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi
    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi

    14 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-strengthens-leadership-team-with-key-hires-to-support-the-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302274366.html

    PR NEWSWIRE
    14 Oct 2024
    Share Share
    Orasis Pharma Completes $78 Million Financing to Launch Qlosia
    Orasis Pharma Completes $78 Million Financing to Launch Qlosia

    08 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-completes-78-million-financing-to-support-commercial-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302269236.html

    PR NEWSWIRE
    08 Oct 2024
    Share Share
    Orasis gains FDA approval for presbyopia eye drops
    Orasis gains FDA approval for presbyopia eye drops

    19 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html

    PR NEWSWIRE
    19 Oct 2023
    Share Share